Trials / Completed
CompletedNCT02312765
Reducing Heart Failure Re-admissions by Enhancing Sleep Apnea Treatment Adherence
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 146 (actual)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Sleep apnea, characterized by abnormal breathing at night, is often untreated in patients with heart failure. Helping patients to effectively use the most common form of treatment for sleep apnea, positive airway pressure therapy, can improve their heart function. This can reduce the likelihood that the patient will be re-admitted to the hospital. AirCareLabs has developed an innovative solution that allows patients to communicate with health care providers 24 hours a day, thus allowing them to get the help they need to effectively use positive airway pressure and thereby reduce the risk of being re-admitted to the hospital.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | AirCare App | Tablet software to encourage adherence and support |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2017-06-01
- Completion
- 2017-12-01
- First posted
- 2014-12-09
- Last updated
- 2020-08-04
- Results posted
- 2020-08-04
Source: ClinicalTrials.gov record NCT02312765. Inclusion in this directory is not an endorsement.